Parkside Financial Bank & Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $329K | Buy |
1,314
+56
| +4% | +$13.9K | 0.03% | 330 |
|
|
2025
Q4 | $346K | Sell |
1,258
-74
| -6% | -$20.2K | 0.03% | 325 |
|
|
2025
Q3 | $349K | Buy |
1,332
+14
| +1% | +$3.4K | 0.03% | 315 |
|
|
2025
Q2 | $288K | Buy |
1,318
+51
| +4% | +$10.9K | 0.03% | 346 |
|
|
2025
Q1 | $284K | Buy |
1,267
+36
| +3% | +$9.92K | 0.04% | 320 |
|
|
2024
Q4 | $403K | Sell |
1,231
-163
| -12% | -$51.3K | 0.05% | 235 |
|
|
2024
Q3 | $418K | Buy |
1,394
+7
| +0.5% | +$2.14K | 0.06% | 228 |
|
|
2024
Q2 | $457K | Buy |
1,387
+96
| +7% | +$33.9K | 0.07% | 199 |
|
|
2024
Q1 | $511K | Buy |
1,291
+219
| +20% | +$81K | 0.08% | 187 |
|
|
2023
Q4 | $377K | Buy |
1,072
+187
| +21% | +$66.2K | 0.07% | 217 |
|
|
2023
Q3 | $332K | Sell |
885
-14
| -2% | -$5.41K | 0.08% | 191 |
|
|
2023
Q2 | $344K | Buy |
899
+110
| +14% | +$39.3K | 0.08% | 184 |
|
|
2023
Q1 | $273K | Buy |
789
+114
| +17% | +$33.3K | 0.07% | 187 |
|
|
2022
Q4 | $159K | Sell |
675
-41
| -6% | -$9.72K | 0.05% | 266 |
|
|
2022
Q3 | $176K | Buy |
716
+80
| +13% | +$24.4K | 0.06% | 232 |
|
|
2022
Q2 | $192K | Buy |
636
+24
| +4% | +$7.81K | 0.06% | 229 |
|
|
2022
Q1 | $251K | Sell |
612
-90
| -13% | -$35.2K | 0.07% | 208 |
|
|
2021
Q4 | $329K | Sell |
702
-53
| -7% | -$22.8K | 0.08% | 172 |
|
|
2021
Q3 | $320K | Buy |
755
+11
| +1% | +$4.64K | 0.09% | 149 |
|
|
2021
Q2 | $267K | Buy |
744
+44
| +6% | +$14.5K | 0.08% | 168 |
|
|
2021
Q1 | $197K | Sell |
700
-22
| -3% | -$6.3K | 0.06% | 201 |
|
|
2020
Q4 | $205K | Buy |
722
+46
| +7% | +$12.9K | 0.06% | 195 |
|
|
2020
Q3 | $186K | Sell |
676
-177
| -21% | -$46.8K | 0.06% | 189 |
|
|
2020
Q2 | $194K | Buy |
853
+17
| +2% | +$3.34K | 0.06% | 203 |
|
|
2020
Q1 | $127K | Sell |
836
-31
| -4% | -$4.77K | 0.05% | 217 |
|
|
2019
Q4 | $130K | Buy |
867
+24
| +3% | +$3.49K | 0.04% | 247 |
|
|
2019
Q3 | $120K | Sell |
843
-11
| -1% | -$1.51K | 0.04% | 241 |
|
|
2019
Q2 | $107K | Buy |
854
+35
| +4% | +$4.13K | 0.03% | 261 |
|
|
2019
Q1 | $90K | Sell |
819
-18
| -2% | -$1.87K | 0.03% | 274 |
|
|
2018
Q4 | $82K | Buy |
837
+64
| +8% | +$6.94K | 0.03% | 274 |
|
|
2018
Q3 | $95K | Buy |
773
+218
| +39% | +$24.4K | 0.03% | 264 |
|
|
2018
Q2 | $55K | Buy |
555
+19
| +4% | +$1.75K | 0.02% | 339 |
|
|
2018
Q1 | $47K | Sell |
536
-48
| -8% | -$4.49K | 0.02% | 359 |
|
|
2017
Q4 | $58K | Sell |
584
-44
| -7% | -$4.31K | 0.02% | 328 |
|
|
2017
Q3 | $60K | Sell |
628
-11
| -2% | -$995 | 0.02% | 305 |
|
|
2017
Q2 | $60K | Buy |
+639
| New | +$58.8K | 0.02% | 288 |
|
Other funds holding WST
VCM
VPM
GIM
Parkside Financial Bank & Trust's WST Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its West Pharmaceutical (WST) stake by 4.5% in Q1 2026, buying an estimated $13.9K and bringing the position to 1,314 shares worth $329K. The position accounts for 0.03% of the portfolio, ranked #330.
Parkside Financial Bank & Trust first reported a position in WST in Q2 2017 and has held it in 36 quarters since. The position peaked at $511K in Q1 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Parkside Financial Bank & Trust held 1,314 shares of West Pharmaceutical worth $329K as of Q1 2026.
- Parkside Financial Bank & Trust bought 56 West Pharmaceutical shares in Q1 2026, an estimated $13.9K.
- West Pharmaceutical made up 0.03% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #330 holding.
- Parkside Financial Bank & Trust first reported a position in West Pharmaceutical in Q2 2017 and has held it in 36 quarters since.
- Parkside Financial Bank & Trust's West Pharmaceutical position peaked at $511K in Q1 2024.
- 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.